Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks hit by fears over growth, US earnings

Wed, 17th Apr 2013 16:50

Fears over economic growth and a raft of disappointing earnings in the States weighed heavily on global markets on Wednesday, while a number of heavyweight stocks going ex-dividend dampened the FTSE 100 in London.Bank of America (BofA) was the first major US bank to miss forecasts this earnings season, while results from Intel, Yahoo and Abbott Laboratories also failed to impress. Nervousness surrounding Apple ahead of its quarterly report next week also hit markets in New York, causing Wall Street benchmarks to fall sharply after the opening bell.Global growth fears have hit European indices over the last few days after a surprise slowdown was reported in China in the first quarter. These concerns were compounded yesterday when the International Monetary Fund (IMF) revised lower its forecasts for global economic growth, cutting estimates for the UK, US, Eurozone and China.Comments from Jens Weidmann, the head of Germany's Bundesbank, shook sentiment today. In an interview with The Wall Street Journal, Weidmann said that the recovery in Europe could take as much as a decade to overcome.Unconfirmed rumours of a German credit rating downgrade were also giving investors more reasons to be cautious this morning, as well as the UK unemployment rate rising from 7.8% to 7.9% in the three months to February.The minutes from the latest Bank of England's Monetary Policy Committee (MPC) meeting released this morning showed that policymakers were split six to three in favour of maintaining the asset purchase programme at £375bn, as expected. They voted unanimously to keep the Bank Rate at 0.5%.FTSE 100: Tullow Oil dives on drilling plansTullow Oil saw its shares drop significantly after its joints venture partner Northern Petroleum gave an update on one of its wells at its joint venture project in French Guiana. Following an announcement by Northern Petroleum, the company confirmed that the GM-ES-3 well, which to-date has had no significant hydrocarbon shows, will be drilled deeper in the hope that it will provide information that is crucial to developing the companies' understanding of the exploration potential of the area. Fresnillo, Resolution, BAE Systems, BG Group, and Petrofac were all lower after going ex-dividend, meaning that new investors will not be able to get their hands on the latest dividend payments.Tesco was also lower after posting its first decline in annual profits in two decades. The supermarket giant reported an underlying pre-tax profit of £3.5bn in the year to February 23rd 2013, a 10.7% fall from the £3.92bn the previous year. Meanwhile, financial service company Hargreaves Lansdown said assets under administration (AuA) reached record levels in the last three months as investor confidence continued to improve. AuA increased by £4.7bn in the three months to March 31st to £35.1bn. Retailer Burberry was also a strong performer after the luxury brand delivered a rise in underlying revenue in the second half as strong growth in the Retail division continued to offset a weaker performance in Wholesale. ARM Holdings shares were given a lift after Goldman Sachs lifted its rating for the business from 'buy' to 'conviction buy'. The broker said: "the recent pull-back in ARM's share price provides an attractive entry point into what we continue to view as one of the most compelling structural growth stories in European technology."FTSE 250: Hikma Pharmaceuticals hit by target price cutHikma Pharmaceuticals was a heavy faller today after going ex-dividend and being hit by a target price cut from Jefferies, from 1,150p to 1,040p. The cut came after the group announced its plan to hold on to its global injectables business.Moneysupermarket.com rose after Westhouse Securities moved its target price from 195p to 210p and upgraded from 'neutral' to 'add'. Pubs group Marston's climbed despite warning on operating profit, saying that it expects to reduce operating costs by around £3.0m per year, with about half of this amount benefiting the results for the second half of this year.FTSE 100 - RisersHargreaves Lansdown (HL.) 949.00p +5.44%Burberry Group (BRBY) 1,289.00p +1.82%Centrica (CNA) 383.00p +1.78%Severn Trent (SVT) 1,760.00p +1.27%United Utilities Group (UU.) 740.00p +1.16%Admiral Group (ADM) 1,317.00p +1.00%SSE (SSE) 1,536.00p +0.99%Rolls-Royce Holdings (RR.) 1,125.00p +0.90%Marks & Spencer Group (MKS) 395.00p +0.89%Carnival (CCL) 2,270.00p +0.80%FTSE 100 - FallersTullow Oil (TLW) 982.50p -9.03%Resolution Ltd. (RSL) 254.10p -7.93%Fresnillo (FRES) 1,074.00p -7.49%Polymetal International (POLY) 706.00p -5.11%Petrofac Ltd. (PFC) 1,278.00p -4.63%Evraz (EVR) 158.50p -4.46%Antofagasta (ANTO) 906.00p -4.03%Tesco (TSCO) 369.75p -3.92%BG Group (BG.) 1,037.50p -3.85%Rio Tinto (RIO) 2,854.50p -3.61%FTSE 250 - RisersLaird (LRD) 213.80p +3.04%Thomas Cook Group (TCG) 117.60p +2.26%Moneysupermarket.com Group (MONY) 189.70p +2.15%LondonMetric Property (LMP) 112.70p +2.08%Betfair Group (BET) 788.00p +1.68%Sports Direct International (SPD) 424.00p +1.65%Marston's (MARS) 134.50p +1.59%Drax Group (DRX) 617.50p +1.48%Interserve (IRV) 478.00p +1.46%Lancashire Holdings (LRE) 811.50p +1.37%FTSE 250 - FallersKazakhmys (KAZ) 320.10p -7.41%Hikma Pharmaceuticals (HIK) 917.50p -6.85%Ferrexpo (FXPO) 162.30p -6.51%Bumi (BUMI) 242.60p -5.93%African Barrick Gold (ABG) 170.30p -5.70%Lonmin (LMI) 259.40p -5.57%Morgan Advance Materials (MGAM) 250.90p -4.78%Hays (HAS) 92.70p -4.73%Ophir Energy (OPHR) 387.40p -4.72%Fenner (FENR) 366.20p -4.66%
More News
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.